Should I Buy ABBV Stock in 2026?
Data-driven analysis and honest assessment for AbbVie Inc
Current Price: $220.04P/E: 166.7
Decision Score
Weak
Based on 6 fundamental factors
Score Breakdown:
Very high P/E of 166.7 suggests overvaluation
Declining -0%
Thin margins (0% net)
Financial health data limited
Strong FCF yield of 5.3%
Balanced insider activity
Key Investment Metrics
Current Price
$220.04
P/E Ratio
166.73
Revenue Growth
0.1%
Profit Margin
0.0%
Market Cap
$389.0B
Dividend Yield
0.03%
How ABBV Compares to Competitors
Understanding how ABBV stacks up against peers helps inform your investment decision.
How ABBV Compares to Peers
Upcoming Events for ABBV
+5 Reasons TO Buy ABBV
1. High gross margins of 71%
strongGross margins above 50% typically indicate strong brand value or intellectual property moats.
2. High free cash flow yield of 5.3%
moderateFCF yield above 5% means substantial cash generation for dividends, buybacks, or reinvestment.
3. Large-cap stability and market leadership
moderateWith market cap over $100B, this company has established leadership and resources to weather cycles.
-5 Reasons NOT to Buy ABBV
1. Expensive valuation at 167x earnings
high riskP/E of 167 is significantly above averages. High expectations leave little room for disappointment.
2. Thin profit margins of 0.0%
high riskLow margins provide little cushion against cost increases or pricing pressure.
3. Minimal revenue growth
low riskGrowth of 0.1% barely keeps pace with inflation.
Who Should Buy ABBV?
Investment Profile
Risk Level
High
Recommended Holding Period
3-5 years
Best For:
- ✓
Momentum Traders
High-growth profile attracts momentum
Not Suitable For:
- ✗
Growth Investors
Limited 0% growth may disappoint
- ✗
Value Investors
Premium P/E of 167 doesn't fit value criteria
- ✗
Income-Focused Retirees
Low 0.0% yield
- ✗
Risk-Averse Investors
High risk may cause uncomfortable volatility
Consider These Alternatives
If you're interested in ABBV, compare these Healthcare peers:
Pro tip: Compare ABBV directly with competitors using our comparison tool to see which stock better fits your criteria.
Get the Full Picture
Access AI-powered insights, DCF valuations, insider trading data, and real-time analysis for ABBV
Frequently Asked Questions
What is ABBV stock price today?
ABBV (AbbVie Inc) stock is trading at $220.04 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).
Is ABBV stock going up or down today?
ABBV stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.
Should I buy ABBV stock now?
The decision to buy ABBV depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.
Is ABBV a buy, hold, or sell right now?
Our AI-powered analysis provides buy/hold/sell recommendations for ABBV based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.
Is ABBV stock overvalued or undervalued?
ABBV currently trades at a P/E ratio of 166.73, which may indicate premium valuation. Our DCF calculator provides intrinsic value estimates to help determine if ABBV is fairly priced.
What is ABBV's P/E ratio?
ABBV has a price-to-earnings (P/E) ratio of 166.73, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.
What is ABBV's market cap?
ABBV (AbbVie Inc) has a market capitalization of $388.97 billion, making it a large-cap stock.
What is ABBV's price to book ratio?
ABBV trades at a price-to-book (P/B) ratio of 50.46, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.
Deep Dive Analysis
Explore comprehensive analysis tools to make an informed decision about AbbVie Inc
Full Stock Analysis
Complete ABBV overview with charts and data
Is ABBV Undervalued?
DCF valuation and intrinsic value analysis
Dividend Analysis
Yield, payout ratio, and dividend history
Growth Analysis
Revenue, earnings, and expansion metrics
Financial Health
Debt, liquidity, and balance sheet strength
Price Prediction
2026 forecast and price targets
Stock Forecast
12-month price forecast and analyst targets
Earnings Date
Next earnings date and historical results
Compare Before You Buy
See how ABBV stacks up against its competitors
Similar Investment Decisions
Explore investment analyses for stocks similar to AbbVie Inc
Complete ABBV Analysis
Compare ABBV With
Disclaimer
This analysis is for informational purposes only and should not be considered financial advice. The decision score and recommendations are based on quantitative factors and do not account for all risks, your personal financial situation, or qualitative factors. Always do your own research and consider consulting with a financial advisor before making investment decisions.